CN Patent

CN113116843A — 一种含有缬沙坦的药物组合物及其制备方法

Assigned to Fujian Haixi Pharmaceuticals Co Ltd · Expires 2021-07-16 · 5y expired

What this patent protects

本发明提供了一种湿法制粒制备缬沙坦片的方法。该方法将缬沙坦与Delta甘露醇及其他药学上可接受的辅料充分混合，加入粘合剂湿法制粒，干燥后再外加其他药学上可接受的辅料混合，经压片，包衣制得缬沙坦片。该方法制备工艺简单，制得的片剂溶出度好、稳定性高，适合工业生产。

USPTO Abstract

本发明提供了一种湿法制粒制备缬沙坦片的方法。该方法将缬沙坦与Delta甘露醇及其他药学上可接受的辅料充分混合，加入粘合剂湿法制粒，干燥后再外加其他药学上可接受的辅料混合，经压片，包衣制得缬沙坦片。该方法制备工艺简单，制得的片剂溶出度好、稳定性高，适合工业生产。

Drugs covered by this patent

cyclobenzaprine-hydrochloride (CYCLOBENZAPRINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN113116843A
Jurisdiction: CN
Classification: —
Expires: 2021-07-16
Drug substance claim: No
Drug product claim: No
Assignee: Fujian Haixi Pharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.